Carlo F. Selmi

Via Rita Levi Montalcini 4, Pieve Emanuele
Milan, 20072, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 320 publications

The placebo effect in psoriatic arthritis.

The placebo effect in psoriatic arthritis.

Journal: Autoimmunity reviews

Published: July 30, 2026

Combined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: Phenotypes matter.

Combined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: Phenotypes matter.

Journal: Autoimmunity reviews

Published: April 14, 2026

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 25, 2026

Automated high-resolution CT analysis outperforms visual assessment in predicting interstitial lung disease progression in SSc.

Automated high-resolution CT analysis outperforms visual assessment in predicting interstitial lung disease progression in SSc.

Journal: Rheumatology (Oxford, England)

Published: March 16, 2026

Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition.

Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition.

Journal: Journal of autoimmunity

Published: February 11, 2026

Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study.

Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study.

Journal: Rheumatology and therapy

Published: December 16, 2025

Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis.

Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis.

Journal: Arthritis research & therapy

Published: December 11, 2025

Psoriatic microRNAs induce NK cell activation via an innate immune crosstalk abrogated by the Toll-like receptor 7/8 antagonist Enpatoran.

Psoriatic microRNAs induce NK cell activation via an innate immune crosstalk abrogated by the Toll-like receptor 7/8 antagonist Enpatoran.

Journal: Journal of translational medicine

Published: December 08, 2025

Psoriatic microRNAs induce NK cell activation via an innate immune crosstalk abrogated by the Toll-like receptor 7/8 antagonist Enpatoran.

Psoriatic microRNAs induce NK cell activation via an innate immune crosstalk abrogated by the Toll-like receptor 7/8 antagonist Enpatoran.

Journal: Journal of translational medicine

Published: December 08, 2025

Modulation of proinflammatory but not regulatory cytokines by in vitro JAK inhibition in peripheral blood B-cells of patients with psoriatic arthritis.

Modulation of proinflammatory but not regulatory cytokines by in vitro JAK inhibition in peripheral blood B-cells of patients with psoriatic arthritis.

Journal: Journal of dermatological science

Published: December 04, 2025

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.

Journal: Frontiers in pharmacology

Published: November 29, 2025

The erosion of seronegative autoimmune diseases through the lens of autoantibodies.

The erosion of seronegative autoimmune diseases through the lens of autoantibodies.

Journal: The Lancet. Rheumatology

Published: November 11, 2025

Showing 1-12 of 320

Last Updated: 09/26/2026